Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected quarterly sales on Tuesday as the Kleenex tissue maker benefited from a recovery in demand.
With the S&P 500 (^GSPC -1.46%) yield at just 1.2%, it has become more challenging to find companies or exchange-traded funds (ETFs) that can provide a steady and sizable stream of passive income. But that doesn't mean there aren't viable options if you know where to look.
KMB's Q4 results are likely to reflect a challenging consumer environment with soft demand, retail inventory reductions and currency risks.
Besides Wall Street's top -and-bottom-line estimates for Kimberly-Clark (KMB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We think that Colgate-Palmolive stock (NYSE: CL) is currently a better pick over its industry peer – Kimberly-Clark stock (NYSE: KMB). CL stock trades at 3.5x trailing revenues, versus 2.1x for KMB.
Kimberly-Clark (KMB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
While the near-term outlook remains uncertain, Kimberly-Clark's strategic efforts are likely to support sustainable growth in the medium to long term.
Kimberly-Clark de Mexico shows stronger growth prospects than its U.S. parent, and has nearly doubled its revenues over the past decade. Despite record profits, Kimberly-Clark de Mexico's stock remains undervalued at 11x earnings, offering a roughly 6.5% dividend yield. The stock's underperformance is likely due to political worries, which I believe are overblown.
Kimberly-Clark Corporation's stable business model and consistent dividend growth have made it a long-time favorite for income-focused investors, despite recent underperformance. The company's growth has stalled due to flat revenues, competition from private labels, and challenges in international markets. Cost-cutting and share repurchases are being used to drive profitability, but organic sales growth remains tepid.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Kimberly-Clark Corporation (NYSE:KMB ) Morgan Stanley Global Consumer & Retail Conference December 3, 2024 1:30 PM ET Company Participants Nelson Urdaneta - CFO Chris Jakubik - Head of IR Conference Call Participants Dara Mohsenian - Morgan Stanley Dara Mohsenian All right. Good afternoon, everyone.